The Audiologist Informer

Implementation of a categorization-based perceptual training paradigm could serve as a promising means of tinnitus management by reversing the changes in cortical plasticity seen in tinnitus, according to a new literature review by Grant Searchfield and colleagues.

OTO-313 demonstrated no clinically meaningful improvement versus placebo across all timepoints. Autonomy will discontinue development of OTO-313 and focus on its OTO-413 treatment for hearing loss, following that drug's positive Phase 2a clinical trial results in April 2022.

We can certainly celebrate that cochlear implants have been the most successful neural prosthesis, with one million users globally. However, Dr. Fan Gang-Zen contends that unilateral implant speech recognition in quiet has plateaued since the early 1990s, calling for more interface and collaboration with the general neurotechnology community.

A new report from Apple shows the ways its products are empowering people to be at the center of their personal health journeys—including hearing care and fall prevention—while potentially providing valuable data support for physicians.